During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...

As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, with health experts warning ...

From today, February 3, pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation ...

“Watched my baby with a tube down his throat for eight days and wasn’t sure if I was ever going to hold him again,” Elliot’s ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

Poland recorded over 2,600 cases of whooping cough and more than 16,000 infections with respiratory syncytial virus (RSV) in ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw some participants achieving an 88.94% reduction in viral load.

His mother, Amberlie Reinertsen, says Mason has had lung complications since birth but has never been this sick before.

Over a third of women giving birth got the new RSV vaccine in September, protecting newborns from severe illness. The new maternal Respiratory ...

While no deaths have been reported, hospitals are seeing an influx of patients, particularly children under two with RSV and older adults with the flu. Doctors urge the public to get vaccinated ...